Cannabis Use Disorder Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Cannabis Use Disorder Market is segmented By Treatment (Pharmacotherapy (Synthetic cannabinoids, CB1 receptor antagonists, Antidepressants, Other medications), Behavioral Therapies (Cognitive Behavioral Therapy (CBT), Motivational Enhancement Therapy (MET), Contingency Management (CM))), By Route of Administration (Oral, Transdermal, Inhalation, Sublingual), By End User (Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.
Cannabis Use Disorder Market Size
Market Size in USD
CAGR9.33%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 9.33% |
| Market Concentration | Medium |
| Major Players | Aelis Farma, Indivior, Pfizer, Corbus Pharmaceuticals, Zynerba Pharmaceuticals |
please let us know !
Cannabis Use Disorder Market Analysis
The cannabis use disorder market is estimated to be valued at USD 1.64 Bn in 2024 and is expected to reach USD 3.06 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.33% from 2024 to 2031. With increasing legalization of cannabis for medical and recreational purposes, more people are gaining access and risk developing cannabis use disorder. This growing acceptance and access to cannabis is expected to significantly drive the growth of the cannabis use disorder market over the forecast period.